NeuraLace Gets 510(k) Clearance for Nerve Pain Relief Device

June 21, 2021

NeuraLace Medical’s Axon Therapy nerve pain relief device has received FDA 510(k) marketing clearance.

The device delivers focused magnetic pulses that activate damaged peripheral nerves to provide relief from chronic nerve pain, offering an alternative to the use of opioids.

"We're excited to offer patients a method of relief that is nonaddictive and noninvasive," said Sean Edwards, the company’s executive chairman.

View today's stories